AMBER OKUBO: Open Payments
NPI 1609330356 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 12 payments from 6 companies in 2025. Trend: 2023 $421 · 2024 $306 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $107 |
| AKEBIA THERAPEUTICS INC | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: IBSRELA, Vafseo, FARXIGA, JARDIANCE, VELPHORO, VOYXACT.
Industry payments across MD — which companies pay providers there.
